Cargando…

Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases

Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor, and due to its unique features, its management is certainly one of the most challenging ones among all cancers. N6-isopentenyladenosine (IPA) and its analog N6-benzyladenosine (N6-BA) are modified nucleosides endowed wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proto, Maria Chiara, Fiore, Donatella, Piscopo, Chiara, Laezza, Chiara, Bifulco, Maurizio, Gazzerro, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086827/ https://www.ncbi.nlm.nih.gov/pubmed/35559231 http://dx.doi.org/10.3389/fphar.2022.815646

Ejemplares similares

Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
por: Bifulco, Maurizio, et al.
Publicado: (2021)

The Endocannabinoid System: A Target for Cancer Treatment
por: Laezza, Chiara, et al.
Publicado: (2020)

Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
por: Proto, Maria Chiara, et al.
Publicado: (2021)

N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor
por: Fiore, Donatella, et al.
Publicado: (2019)

Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids
por: Fiore, Donatella, et al.
Publicado: (2018)

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
por: Proto, Maria Chiara, et al.
Publicado: (2017)

Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment
por: Proto, Maria Chiara, et al.
Publicado: (2023)

In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks Comptes Rendus
por: Fiore, Donatella, et al.
Publicado: (2022)

N(6)-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
por: Navarra, Giovanna, et al.
Publicado: (2020)

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
por: Ciaglia, Elena, et al.
Publicado: (2015)

Towards an Improvement of Anticancer Activity of Benzyl Adenosine Analogs
por: Covelli, Verdiana, et al.
Publicado: (2021)

Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma
por: Abate, Mario, et al.
Publicado: (2017)

Multifaceted Role of PRDM Proteins in Human Cancer
por: Casamassimi, Amelia, et al.
Publicado: (2020)

N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition
por: Pagano, Cristina, et al.
Publicado: (2021)

Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer Patients
por: Pagano, Cristina, et al.
Publicado: (2021)

Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa
por: Ciaglia, Elena, et al.
Publicado: (2017)

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2013)

Statins in coronavirus outbreak: It’s time for experimental and clinical studies
por: Bifulco, Maurizio, et al.
Publicado: (2020)

Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
por: Ciechomska, Iwona Anna, et al.
Publicado: (2018)

RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer
por: Di Donato, Marzia, et al.
Publicado: (2023)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

Molecular Mechanism of Cannabinoids in Cancer Progression
por: Pagano, Cristina, et al.
Publicado: (2021)

Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
por: Song, Liying, et al.
Publicado: (2022)

Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy
por: Wu, Hao, et al.
Publicado: (2023)

p53 regulates the mevalonate pathway in human glioblastoma multiforme
por: Laezza, C, et al.
Publicado: (2015)

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
por: Pasquini, Silvia, et al.
Publicado: (2022)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells
por: Pagano, Cristina, et al.
Publicado: (2022)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
por: Wang, Siqi, et al.
Publicado: (2022)

Cannabinoids: Therapeutic Use in Clinical Practice
por: Pagano, Cristina, et al.
Publicado: (2022)

Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival
por: Robinson, C G, et al.
Publicado: (2010)

Nitric Oxide Prevents Glioblastoma Stem Cells’ Expansion and Induces Temozolomide Sensitization
por: Salvatori, Luisa, et al.
Publicado: (2023)

The A(2B) Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells
por: Giacomelli, Chiara, et al.
Publicado: (2018)

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019)

Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
por: Tso, Jonathan L., et al.
Publicado: (2015)

Cannabinoids in the Modulation of Oxidative Signaling
por: Pagano, Cristina, et al.
Publicado: (2023)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
por: Chen, Jigang, et al.
Publicado: (2021)

The PI3K Inhibitor XH30 Enhances Response to Temozolomide in Drug-Resistant Glioblastoma via the Noncanonical Hedgehog Signaling Pathway
por: Ji, Ming, et al.
Publicado: (2021)

The effect of an adenosine A(2A) agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma
por: Jackson, Sadhana, et al.
Publicado: (2018)

Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
por: Potthoff, Anna-Laura, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ndv7m7ns5lc7a5jdt25dtc6li